Série de poudre brute anesthésique locale Bupivacaïne
Détails de base:
Nom du produit: Bupivacaine hydrochloride
CAS: 14252-80-3
MF: C18H28N2O.ClH
MW: 324.89
EINECS: 241-917-8
Point de fusion: 249-251°C
Température de stockage: Réfrigérateur
Apparence: White Solid
Usage: Antineoplastic ; Sodium channel blocker, local anesthetic
La description:
Bupivacaine Hydrochloride is 2-Piperidinecarboxamide , 1-butyl-N-(2,6-dimethylphenyl)- , monohydrochloride , monohydrate , a white crystalline powder that is freely soluble in 95 percent ethanol , soluble dans l'eau , and slightly soluble in chloroform or acetone.Bupivacaine Hydrochloride is available in sterile isotonic solutions with and without epinephrine (as bitartrate) 1 : 200 ,000 for injection via local infiltration, peripheral nerve block , and caudal and lumbar epidural blocks . Solutions of Bupivacaine Hydrochloride may be autoclaved if they do not contain epinephrine . Solutions are clear and colorless. Bupivacaine is related chemically and pharmacologically to the aminoacyl local anesthetics .They differ in this respect from the procaine-type local anesthetics , which have an ester linkage.
Résultat du test de laboratoire:
|
Nom du produit: Bupivacaine hydrochloride |
|
Batch No.: YY20170429 |
Quantity: 10KG |
|
Manufacturing Date: 2017/04/29 |
Expiry. Date: 2019/04/28 |
|
Standard: USP32 |
|
Articles de test |
Standard |
Résultats de test |
|
Personnage |
Poudre cristalline blanche |
Conforme |
|
Identification |
ET
UV
The aqueous layer responds to the tests for
Chloride |
Conforme
Conforme
Conforme |
|
PH |
4.5-6.0 |
5.8 |
|
Heavy metal |
Pas plus de 0.001% |
Conforme |
|
L'eau |
4.0%-6.0% |
5.5% |
|
Résidu à l'allumage |
Pas plus de 0.1% |
0.04% |
|
Limit of residual solvents |
Pas plus de 2% |
Conforme |
|
Chromatographic purity |
Impureté totale:<2.0%
Individual impurity:<0.5% |
Conforme
Conforme |
|
Essai |
98.5%-101.5% |
99.50% |
|
Conclusion |
It conforms to USP32 standard |
|
Poudre anesthésique locale
|
|
Benzocaïne |
Prilocaïne |
|
Benzocaïne HCL |
Procaïne |
|
Bupivacaïne HCL |
Procaïne HCL |
|
Lévobupivacaïne HCL |
Propitocaïne HCL |
|
Lidocaïne |
Ropivacaïne HCL |
|
Lidocaïne HCL |
Tétracaïne |
|
Pramoxine HCL |
Tétracaïne HCL |
Directeur commercial